Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Eitan Friedman

Showing results (41-50 of 375) with videos related to

Pageof 38
Sort By:
European Journal of Human Genetics : EJHG|October 31, 2002
Androgen receptor CAG repeat length in Jewish Israeli women who are BRCA1/2 mutation carriers: association with breast/ovarian cancer phenotypeEfrat Dagan, Eitan Friedman, Tamar Paperna, et al.
Cancer Causes & Control : CCC|December 1, 2018
The rate of the recurrent MSH6 mutations in Ashkenazi Jewish breast cancer patientsRinat Bernstein-Molho, Yael Laitman, Hagit Schayek, et al.
Cancer|June 22, 2021
Yield of targeted genotyping for the recurring pathogenic variants in cancer susceptibility genes in a healthy, multiethnic Israeli populationRinat Bernstein-Molho, Lee Galmor, Yael Laitman, et al.
Cancer Genetics|March 12, 2026
Outcomes of multigene panel testing for hereditary cancer in two Israeli medical centers 2013-2024Yael Laitman, Shelley Zalmanoviz, Iris Netzer, et al.
Breast Cancer Research and Treatment|January 15, 2021
Double heterozygosity for TP53 and BRCA1 mutations: clinical implications in populations with founder mutationsHagit Shani, Rinat Bernstein-Molho, Yael Laitman, et al.
Breast Cancer Research and Treatment|November 25, 2011
Phenocopy breast cancer rates in Israeli BRCA1 BRCA2 mutation carrier families: is the risk increased in non-carriers?Shiri Bernholtz, Yael Laitman, Bella Kaufman, et al.
Developmental Neuroscience|April 18, 2009
Prenatal cocaine increases dendritic spine density in cortical and subcortical brain regions of the ratMaya Frankfurt, Hoau-Yan Wang, Naydu Marmolejo, et al.
International Journal of Cancer|December 3, 2003
CHEK2*1100delC and male breast cancer risk in IsraelTal Ohayon, Inbar Gal, Ruth Gershoni Baruch, et al.
The Israel Medical Association Journal : IMAJ|May 14, 2025
CA125 Serum Levels in BRCA1/BRCA2 Pathogenic Sequence Variant Carriers as an Ovarian Cancer Screening Tool: A Longitudinal StudyDana Madorsky Feldman, Yael Laitman, Dana Albagli, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|June 15, 2013
Parkinson's disease genes do not segregate with breast cancer genes' lociEfrat Kravitz, Yael Laitman, Sharon Hassin-Baer, et al.
Pageof 38

Showing results (41-50 of 375) with videos related to

Sort By:
Pageof 38
European Journal of Human Genetics : EJHG|October 31, 2002
Androgen receptor CAG repeat length in Jewish Israeli women who are BRCA1/2 mutation carriers: association with breast/ovarian cancer phenotypeEfrat Dagan, Eitan Friedman, Tamar Paperna, et al.
Cancer Causes & Control : CCC|December 1, 2018
The rate of the recurrent MSH6 mutations in Ashkenazi Jewish breast cancer patientsRinat Bernstein-Molho, Yael Laitman, Hagit Schayek, et al.
Cancer|June 22, 2021
Yield of targeted genotyping for the recurring pathogenic variants in cancer susceptibility genes in a healthy, multiethnic Israeli populationRinat Bernstein-Molho, Lee Galmor, Yael Laitman, et al.
Cancer Genetics|March 12, 2026
Outcomes of multigene panel testing for hereditary cancer in two Israeli medical centers 2013-2024Yael Laitman, Shelley Zalmanoviz, Iris Netzer, et al.
Breast Cancer Research and Treatment|January 15, 2021
Double heterozygosity for TP53 and BRCA1 mutations: clinical implications in populations with founder mutationsHagit Shani, Rinat Bernstein-Molho, Yael Laitman, et al.
Breast Cancer Research and Treatment|November 25, 2011
Phenocopy breast cancer rates in Israeli BRCA1 BRCA2 mutation carrier families: is the risk increased in non-carriers?Shiri Bernholtz, Yael Laitman, Bella Kaufman, et al.
Developmental Neuroscience|April 18, 2009
Prenatal cocaine increases dendritic spine density in cortical and subcortical brain regions of the ratMaya Frankfurt, Hoau-Yan Wang, Naydu Marmolejo, et al.
International Journal of Cancer|December 3, 2003
CHEK2*1100delC and male breast cancer risk in IsraelTal Ohayon, Inbar Gal, Ruth Gershoni Baruch, et al.
The Israel Medical Association Journal : IMAJ|May 14, 2025
CA125 Serum Levels in BRCA1/BRCA2 Pathogenic Sequence Variant Carriers as an Ovarian Cancer Screening Tool: A Longitudinal StudyDana Madorsky Feldman, Yael Laitman, Dana Albagli, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|June 15, 2013
Parkinson's disease genes do not segregate with breast cancer genes' lociEfrat Kravitz, Yael Laitman, Sharon Hassin-Baer, et al.
Pageof 38